0001214659-23-006373.txt : 20230502 0001214659-23-006373.hdr.sgml : 20230502 20230502163026 ACCESSION NUMBER: 0001214659-23-006373 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230428 FILED AS OF DATE: 20230502 DATE AS OF CHANGE: 20230502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jackman Stephan CENTRAL INDEX KEY: 0001864257 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40483 FILM NUMBER: 23879589 MAIL ADDRESS: STREET 1: C/O ALZAMEND NEURO, INC. STREET 2: 3802 SPECTRUM BOULEVARD, SUITE 112C CITY: TAMPA STATE: FL ZIP: 33612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alzamend Neuro, Inc. CENTRAL INDEX KEY: 0001677077 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811822909 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 3500 LENOX RD. NE STREET 2: SUITE 1500 CITY: ATLANTA STATE: GA ZIP: 30326 BUSINESS PHONE: 844-722-6333 MAIL ADDRESS: STREET 1: 3500 LENOX RD. NE STREET 2: SUITE 1500 CITY: ATLANTA STATE: GA ZIP: 30326 4 1 marketforms-61359.xml PRIMARY DOCUMENT X0407 4 2023-04-28 0001677077 Alzamend Neuro, Inc. ALZN 0001864257 Jackman Stephan 3480 PEACHTREE ROAD NE SECOND FLOOR SUITE 103 ATLANTA GA 30326 true true false false Chief Executive Officer 0 Common Stock 2023-04-28 4 P false 37000 0.5405 A 45500 D The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.5405. The range of purchase prices on the transaction date was $0.5398 to $0.5499 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. /s/ Stephan Jackman 2023-05-02